How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come.


Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
12 2022
Historique:
received: 07 06 2022
accepted: 06 09 2022
pubmed: 28 9 2022
medline: 18 11 2022
entrez: 27 9 2022
Statut: ppublish

Résumé

In recent years, clinical use of novel advanced imaging modalities in prostate cancer detection, staging, and therapy has intensified and is currently reforming clinical guidelines. In the future, advanced imaging technologies will continue to develop and become even more accurate, which will offer new opportunities for improving patient selection, surgical treatment, and radiotherapy, with the potential to guide prostate cancer therapy.

Identifiants

pubmed: 36167598
pii: S0302-2838(22)02634-3
doi: 10.1016/j.eururo.2022.09.005
pii:
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

578-580

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Melline G M Schilham (MGM)

Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands; Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: melline.schilham@radboudumc.nl.

Mark Rijpkema (M)

Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.

Tom Scheenen (T)

Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.

Rick Hermsen (R)

Department of Nuclear Medicine, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.

Jelle O Barentsz (JO)

Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.

J P Michiel Sedelaar (JP)

Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Heidi Kusters-Vandevelde (H)

Department of Pathology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.

Linda G W Kerkmeijer (LGW)

Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Diederik M Somford (DM)

Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.

Martin Gotthardt (M)

Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH